Perrigo To Launch Private Label Mucinex, Prevacid, With An Eye On Lipitor
This article was originally published in The Tan Sheet
Executive Summary
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.
You may also be interested in...
Perrigo Nutritional Dip Riles Analysts Amid Record Consumer Sales
A 14% decline in nutritional segment sales that slightly hampered Perrigo Co.’s consumer business revenue could affect the firm’s stock valuation if it cannot turn the division around, multiple analysts said. But Perrigo says the dip was expected and temporary,
Perrigo Nutritional Dip Riles Analysts Amid Record Consumer Sales
A 14% decline in nutritional segment sales that slightly hampered Perrigo Co.’s consumer business revenue could affect the firm’s stock valuation if it cannot turn the division around, multiple analysts said. But Perrigo says the dip was expected and temporary,
Brand-Boosting Schiff Nutrition Sees Upside In Top-Selling Supplements
Schiff Nutrition CEO Tarang Amin, a veteran of managing brands for Clorox and P&G, sees additional upside in top-selling brands such as MegaRed and Move Free. The firm also is de-emphasizing its struggling private label business.